Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2001-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s002620100202PMID 11570581PMCID PMC11036843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-6 Transduction of a Rat T9 Glioma Clone Results in Attenuated Tumorigenicity and Induces Glioma Immunity in Fischer F344 Rats

  2004cited by this paper
• Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

  2000cited by this paper
• Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption.

  2000cited by this paper
• Antigen-processing machinery breakdown and tumor growth.

  2000cited by this paper
• Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.

  2000cited by this paper
• Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.

  1999cited by this paper
• Cancer therapy using a self-replicating RNA vaccine

  1999cited by this paper
• Association of the Adaptor Molecule Lat with Cd4 and Cd8 Coreceptors Identifies a New Coreceptor Function in T Cell Receptor Signal Transduction

  1999cited by this paper
• Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.

  1999cited by this paper
• Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.

  1999cited by this paper
• Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

  1999cited by this paper
• Immune surveillance against a solid tumor fails because of immunological ignorance.

  1999cited by this paper
• Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

  1999cited by this paper
• Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain

  1999cited by this paper
• Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

  1999cited by this paper
• Immune defects observed in patients with primary malignant brain tumors.

  1999cited by this paper
• Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma.

  1998cited by this paper
• Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.

  1998cited by this paper
• Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.

  1998cited by this paper
• Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.

  1998cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.

  1997cited by this paper
• Sequential development of structural and functional alterations in T cells from tumor-bearing mice.

  1997cited by this paper
• Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.

  1997cited by this paper
• Tumor antigens recognized by T cells.

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Expression of B220 on activated T cell blasts precedes apoptosis.

  1997cited by this paper
• Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.

  1997cited by this paper
• Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.

  1996cited by this paper
• The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice.

  1996cited by this paper
• Induction of apoptosis in mature T cells by tumour necrosis factor

  1995cited by this paper
• Upregulation of surface markers on dying thymocytes

  1995cited by this paper
• Molecular characterization of defective antigen processing in human prostate cancer.

  1995cited by this paper
• Tumor antigens in astrocytic gliomas

  1995cited by this paper
• Gene therapy of metastatic cancer by in vivo retroviral gene targeting

  1995cited by this paper
• T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.

  1995cited by this paper
• Interactions between lymphocytes, macrophages, and central nervous system cells

  1994cited by this paper
• Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

  1994cited by this paper
• Immunobiology of malignant astrocytomas.

  1994cited by this paper
• Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.

  1992cited by this paper
• Modulation of T-cell function by gliomas.

  1991cited by this paper

• Pathological features of tissues and cell populations during cancer cachexia

  2022cites this paper
• Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

  2017cites this paper
• Independent of Antigen Specificity Cells in Murine Tumors Generated T - CD8 - Characterization of Defective CD4

  2017cites this paper
• Novel vaccines for glioblastoma: clinical update and perspective.

  2016cites this paper
• The Journal of Clinical Investigation

  2016cites this paper
• Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers

  2013influential citation
• Characterization of Immune Cell Infiltration Into Canine Intracranial Meningiomas

  2012cites this paper
• Immunotherapy for glioma: promises and challenges.

  2012cites this paper
• Vaccines for glioblastoma and high-grade glioma

  2011cites this paper
• Monitoring immune responses after glioma vaccine immunotherapy.

  2010cites this paper
• Radiation Immunomodulatory Gene Tumor Therapy of Rats with Intracerebral Glioma Tumors

  2010cites this paper
• Biologic principles of immunotherapy for malignant gliomas.

  2010cites this paper
• Regulatory Mechanism of Myeloid Derived Suppressor Cell Activity

  2010cites this paper
• Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

  2009cites this paper
• ESCUELA NACIONAL DE CIENCIAS BIOLÓGICAS SECCIÓN DE ESTUDIOS DE POSGRADO E INVESTIGACIÓN DEPARTAMENTO DE INMUNOLOGÍA Supresión del ambiente inmune por el glioma C6 y la inducción de inmunidad antitumoral con la eliminación de células Treg por toxina pertussis.

  2009cites this paper
• Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice

  2008cites this paper
• Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.

  2008cites this paper
• Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines

  2008cites this paper
• CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism

  2007cites this paper
• Clinico-pathological significance of RCAS1 expression in gliomas: a potential mechanism of tumor immune escape.

  2007cites this paper
• Survival of Rats with N 29 Brain Tumors after Single fraction 5 or 15 Gy Radiotherapy combined with Immunotherapy

  2007cites this paper
• Current immunotherapeutic strategies for central nervous system tumors.

  2007cites this paper
• Immunotherapy for Gliomas: Part II Passive Immunotherapy and Active Immunotherapy

  2007cites this paper
• T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy.

  2006cites this paper
• Immunotherapeutic Approaches for Alzheimer’s Disease

  2006cites this paper
• Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy.

  2006cites this paper
• Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death

  2005cites this paper
• T cell activity in glioma chemoresponsiveness and genetics

  2005influential citation
• Dendritic cell vaccines and immunity in glioma patients.

  2005cites this paper
• Immunotherapy for malignant glioma: current approaches and future directions

  2005cites this paper
• Characterization of Defective CD4−CD8− T Cells in Murine Tumors Generated Independent of Antigen Specificity1

  2004cites this paper
• Cellular immunity and immunotherapy of brain tumors.

  2004cites this paper
• Immunotherapeutic strategies for malignant glioma.

  2004cites this paper
• Thymic Function and Output of Recent Thymic Emigrant T Cells During Intracranial Glioma Progression

  2004cites this paper
• The Neurosurgeon as Local Oncologist: Cellular and Molecular Neurosurgery in Malignant Glioma Therapy

  2003cites this paper
• Immunotherapy of glioblastoma multiforme

  2003cites this paper
• Apoptosis is not correlated with the presence of CD57+ NK-cells in brain metastases

  2003cites this paper
• Immunology and Immunotherapy in Neurosurgical Disease

  2003cites this paper
• Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression

  2003cites this paper
• Tumor escape from immune response: mechanisms and targets of activity.

  2003cites this paper
• Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression

  2002cites this paper
• Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

  2002cites this paper
• All in the head: obstacles for immune rejection of brain tumours

  2002cites this paper